Department of Experimental Clinical Oncology

Error in site JavaScript
Untitled Document


235.      Andersen, J.: Determination of Estrogen receptors in parrafin-embedded tissue: techniques and the value in breast cancer treatment. Acta Oncologica 31: 611-627, 1992.

236.      Becker, U., Andersen, J., Poulsen, H.S. & Horn, T.: Hepatic estrogen receptors in patients with liver disease. A multivariate analysis. Scand. J. Gastroenterol. 27: 355-361, 1992.

237.      Bentzen, S.M.: Steepness of the clinical dose-control curve for oropharyngeal carcinoma and variation in the in vitro radiosensitivity. Int. J. Radiat. Biol. 61: 417-423, 1992.

238.      Bentzen, S.M., Balslev, I., Pedersen, M., Teglbjærg, P.S., Hanberg-Sørensen, F., Bone, J., Jacobsen, N.O., Overgaard, J., Sell, A., Bertelsen, K., Hage, E., Fenger, C., Kronborg, O., Hansen, L., Høstrup, H. &  Nørgaard-Pedersen, B.: Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer. A multivariate regression analysis. Br. J. Cancer 65: 102-107, 1992.

239.      Bentzen, S.M., Lundbeck, F., Christensen, L.L. & Overgaard, J.: Fractionation sensitivity and latency of late radiation injury to the mouse urinary bladder. Radiotherapy and Oncology 25: 301-307, 1992.

240.      Bentzen, S.M. & Thames, H.D.: Overall treatment time and tumor control dose for head and neck tumors: the dog leg revisited. (Letter to the Editor). Radiotherapy and Oncology 25: 143-144, 1992.

241.      Bundgaard, T., Sørensen, F.B., Gaihede, M., Søgaard, H. & Overgaard, J.: Stereologic, histopathologic, flow-cytometric and clinical parameters in the prognostic evaluation of 74 patients with intra-oral squamous cell carcinomas. Cancer 70: 1-13, 1992.

242.      Carl, J., Christensen, T.B. & von der Maase, H.: Cisplatinum dose dependent response in germ cell cancer evaluated by tumor marker modelling. Acta Oncologica 31: 749-753, 1992.

243.      Chaplin, D.J. & Horsman, M.R.: Tumour blood flow changes induced by chemical modifiers of radiation response. Int. J. Radiat. Oncol. Biol. Phys. 22: 459-462, 1992.

244.      Damstrup, L., Andersen, J., Kufe, D.W., Hayes, D.F. & Poulsen, H.S.: Immunocytochemical determination of the estrogen-regulated proteins Me 24,000, Mr 52,000 and DF3 breast cancer associated antigen. Clinical value in advanced breast cancer and correlation with estrogen receptor. Ann. Oncol. 3: 71-77, 1992.

245.      Grau, C., Horsman, M.R. & Overgaard, J.: Improving the radiation response in a C3H mouse mammary carcinoma by normobaric oxygen and carbogen breating. Int. J. Radiation Oncology Biol. Phys. 22: 415-419, 1992.

246.      Grau, C., Horsman, M.R. & Overgaard, J.: Influence of carboxyhemoglobin on tumor growth and radiation response in an experimental model. Int. J. Radiation Oncology Biol. Phys. 22: 421-424, 1992.

247.      Grau, C., Møller, K., Overgaard, M., Overgaard, J. & Elbrønd, O.: Auditory brainstem responses in patients after radiation therapy for nasopharyngeal carcinoma. Cancer 70: 2396-2401, 1992.

248.      Grau, C. & Overgaard, J.: Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mammary carcinoma in vivo. Cancer Chemother.Pharmacol. 30: 277-280, 1992.

249.      Horsman, M.R.: Carbogen and nicotinamide: expectations too high? Radiotherapy and Oncology 24: 121-122, 1992.

250.      Horsman, M.R. & Chaplin, D.J.: Tumor blod flow changes induced by chemical modifiers of radiation response. Int. J. Radiation Oncology Biol. Phys. 22: 449-462, 1992.

251.      Horsman, M.R., Christensen, K.L. & Overgaard, J.: Relationship between the hydralazine-induced changes in murine tumour blood supply and mouse blood pressure. Int. J. Radiation Oncology Biol. Phys. 22: 445-458, 1992.

252.      Horsman, M.R., Kristjansen, P.E.G., Mizuno, M., Christensen, K.L., Chaplin, D.J., Quistorff, B. & Overgaard, J.: Biochemical andphysiological changes induced by nicotinamide in a C3H mouse mammary carcinoma and CDF1 mice. Int. J. Radiation Oncology Biol. Phys. 22: 451-454, 1992.

253.      Horsman, M.R. & Overgaard, J.: Simultaneous and sequential treatment with radiation and hyperthermia: acomparative assessment. In: Interstitial hyperthermia. Handl-Zeller, L. (ed). Springer Verlag, Wien, New York, pp. 11-33, 1992.

254.      Horsman, M.R. & Overgaard, J.: Overcoming tumour radioresistance resulting from acute hypoxia. Eur. J. Cancer 28: 717-718, 1992.

255.      Horsman, M.R. & Overgaard, J.: BW12C-induced changes in haemoglobin-oxygen affinity in mice and its influence on the radiation response of a C3H mouse mammary carcinoma. Radiotherapy and Oncology 25: 43-48, 1992.

256.      Horsman, M.R. & Overgaard, J.: Overcoming tumour radiation resistance resulting from acute hypoxia. (letter) Eur. J. Cancer 28: 2084-2085, 1992.

257.      Horsman, M.R., Overgaard, J. & Lindegaard, J.L.:  Interaction of hyperthermia and radiation in solid tumours in vivo. in: Dewey, W.C. et al (eds): Radiation Research. A twentieth-century perspective, Vol II. Academic Press, New York, pp 1033-1038, 1992.

258.      Høyer, M. & Nielsen, O.S.: Influence of dose on regeneration of murine hematopoietic stem cells after total body irradiation and 5-fluorouracil. Oncology 49: 166-172, 1992.

259.      Ito, H., Tashiro, K., Stroud, M.R., Ørntoft, T.F., Meldgaard, P., Singhal, A.K. & Hakomori, S-i.: Specificity and immunobiological properties of monoclonal antibody IMH2, established after immunization with Leb/Lea glycosphingolipid, a novel extended type 1 chain antigen. Cancer Res 52: 3739-3745, 1992.

260.      Jensen, P.H., Glieman, J. & Ørntoft, T.F.: Characterization of carbohydrates in the alpha 2-macroglobulin receptor. FEBS Lett. 305: 129-132, 1992.

261.      Johansen, L.V., Mestre, M. & Overgaard, J.: Carcinoma of Nasopharynx: Analysis of treatment results in 167 consecutively admitted patients. Head and Neck 14: 200-207, 1992.

262.      Kvist, E., Sjølin, K.E., Laursen, H., Ørntoft, T.F. & Sturmer, M.A.S.: Sqamous cell metaplasia of the bladder urothelium. Aretrospective study of 36 patients. APMIS 100: 650-654, 1992.

263.      Langkilde, N.C., Wolf, H., Clausen, H., Kjeldsen, T. & Ørntoft, T.F.: Nuclear volume and expression of T-antigen, sialosyl-Tn-antigen and Tn-antigen in carcinoma of the human bladder: relation to tumor recurrence and progression. Cancer 69: 219-227, 1992.

264.      Langkilde, N.C., Wolf, H., Clausen, H. & Ørntoft, T.: Human urinary bladder tumor glycoproteins espressing T-(Gal-$(1-3)Gal-NAc-"-O-R) and T-related antigens: a comparative study by the use of PNA, mono- and polyclonal antibodies. Cancer Res. 52: 5030-5036, 1992.

265.      Langkilde, N.C., Wolf, H, Clausen, H. & Ørntoft, T.: Localisation and identification of T-(Gal$1-3GalNAc"1-O-R) and T-like antigens in experimental rat bladder cancer. J. Urol. 148: 1279-1284, 1992.

266.      Lee, F., Littrup, P.J., Loft Christensen, L., Kelly, B.S., McHugh, T.A., Siders, D.B., Mitchell, A. & Newby, J.E.: Predicted prostate specific antigen results using transrectal ultrasound gland volume. differentiation of benign prostatic hyperplasia and prostate cancer. Cancer 70 (Suppl. 1) 211-220, 1992.

267.      Leer, J.W.H., Davelaar, J., Overgaard, J. & Heeren, G.: Education in radiation oncology in Europe. Int. J. Radiation Oncol. Biol. Phys. 24: 819-823, 1992.

268.      Leer, J.W.H., Overgaard, J. & Heeren, G.: The European core curriculum on training in radiotherapy. Int. J. Radiation Oncol. Biol. Phys. 24: 813-814, 1992.

269.      Lindegaard, J.C.: Thermosentizitation induced by step-down heating. Int. J. Hyperthermia 8: 561-586, 1992.

270.      Lindegaard, J.C., Radacic, M.M., Khalil, A.A., Horsman, M.R. & Overgaard, J.: Cisplatin and hyperthermia treatment of a C3H mammary carcinoma in vivo. Importance of sequence, interval, drug dose and temperature. Acta Oncologica 31: 347-351, 1992.

271.      Lundbeck, F. & Overgaard, J.: Early an late changes in the normal mouse bladder resevoir function due to irradiation and cis-DDP. Br. J. Cancer 66: 99-105, 1992.

272.      Lundbeck, F. & Sjögren, C.: A pharmocological in vitro study of the mouse urinary bladder at the time of acute change in bladder reservoir function after irradiation. J. Urol. 148: 179-182, 1992.

273.      Mandel, U., Langkilde, N.C., Ørntoft, T.F., Therkelsen, M.H., Karkov, J., Reibel, J., White, T., Clausen, H. & Dabelsteen, E. Expression of histo-blood group A/B-gene-defined glycosyltransferases in normal and malignant epithelia: correlation with A/B-carbohydrate expression. Int. J. Cancer 52: 7-12, 1992.

274.      Mao, H.-S., Grau, C. & Overgaard, J.: Interaction of radiation, Misonidazole and hyperthermia in a C3H mammary carcinoma and its surrounding normal tissue in vivo. Int. J. Radiation Oncology, Biol. Phys. 22: 115-122, 1992.

275.      Marcussen, N. & Jacobsen, N.O.: The progression of cisplatin-induced  tubulointerstitial nephropathy in rats. APMIS 100: 256-268, 1992.

276.      Nielsen, N.S.M., Andersen, J., Poulsen, H.S. & Mathiessen, O.: Prediction of hormone responsiveness by mammographic parenchymal pattern in advanced primary breast cancer. Breast Cancer Research and Treatment 23: 219-222, 1992.

277.      Nielsen, O.S., Munro, A.J. & Warde, P.R.: Hyperthermia as a palliative treatment modality: Assesment of response. Int. J. Hyperthermia. 8: 1-10, 1992.

278.      Overgaard, J., Nielsen, J.E. & Grau, C.: Tumor oxygen unloading capacity in patients with squamous cell carcinoma in head and neck. Int. J. Radiation Oncology Biol. Phys. 22: 407-410, 1992.

279.      Overgaard, J., Sand Hansen, H., Overgaard, M., Jørgensen, K., Bastholt, L., Pedersen, M. & Berthelsen, A.: The Danish head and neck cancer study group (DAHANCA) randomized trials with radiosensitizers in carcinoma of tha larynx and pharynx. in: Dewey, W.C. et al (eds): Radiation Research. A twentieth-century perspective, Vol II. Academic Press, New York, pp 573-577, 1992.

280.      Pedersen, D., Bentzen, S.M. & Overgaard, J: Continous versus split-course brachytherapy & external radiotherapy alone in for locally advanced cervical cancer. In: Brachytherapy in the Nordic Countries. Mould, R.F. (ed). Nucletron, Leersum, pp. 114-116, 1992.

281.      Pedersen, D., Overgaard, J., Søgaard, H., Elbrønd, H., Overgaard, M.: Malignant parotid tumours in 110 patients: treatment results and prognosis. Laryngoscope 102: 1064-1069, 1992.

282.      Sørensen, F.B., Bichel, P. & Jacobsen, A.: DNA level and stereologic estimates of nuclear volume in squamous cell carcinomas of the uterine cervix. Cancer 629: 197-99, 1992.

283.      Vestlev, P.M., Pallesen, G., Sandvej, K., Hamilton-Dutoit S.J., & Bentzen, S.M.: Hodgkins disease prognosis is not influenced by EBV-latent membrane protein. Int. J. Cancer 50: 670-671, 1992.

284.      Winther, J., Jensen, O.A., Prause, J.U. & Tommerup, N.: An intraocular retinoblastoma-like tumour suitable for therapeutic research in vivo and in vitro. In: N. Bornfeld et al. (eds): Tumors of the eye, Kugler Publications, Amsterdam/New York, pp 73-78, 1992.

285.      Winther, J. & Overgaard, J.: Anti-tumour effect and eye tissue damage by hematoporphyrin derivatives in combination with light irradiation for management of an intraocular retinoblastoma-like tumour. In: N. Bornfeld et al. (eds): Tumors of the eye, Kugler Publications, Amsterdam/New York, pp 79-82, 1992.

286.      Ørntoft, T.F.: Charbohydrate changes in bladder carcinomas. APMIS, suppl. 27: 181-187, 1992.